BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tkhilaishvili T, Winkler T, Müller M, Perka C, Trampuz A. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2019;64:e00924-19. [PMID: 31527029 DOI: 10.1128/AAC.00924-19] [Cited by in Crossref: 40] [Cited by in F6Publishing: 52] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Jeyaraman M, Jeyaraman N, Konkathi VK, Nallakumarasamy A, Muthu S, Khanna M. Bacteriophage Therapy in Implant-Related Orthopedic Infections. JOIO. [DOI: 10.1007/s43465-022-00728-y] [Reference Citation Analysis]
2 Racenis K, Rezevska D, Madelane M, Lavrinovics E, Djebara S, Petersons A, Kroica J. Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis-A Case Report. Front Med (Lausanne) 2022;9:851310. [PMID: 35547216 DOI: 10.3389/fmed.2022.851310] [Reference Citation Analysis]
3 Chen P, Liu Z, Tan X, Wang H, Liang Y, Kong Y, Sun W, Sun L, Ma Y, Lu H. Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa. Biosci Trends 2022. [PMID: 35444073 DOI: 10.5582/bst.2022.01147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Aranaga C, Pantoja LD, Martínez EA, Falco A. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review. Int J Mol Sci 2022;23:4577. [PMID: 35562968 DOI: 10.3390/ijms23094577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Vázquez R, Díez-martínez R, Domingo-calap P, García P, Gutiérrez D, Muniesa M, Ruiz-ruigómez M, Sanjuán R, Tomás M, Tormo-mas MÁ, García P. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain. Microorganisms 2022;10:717. [DOI: 10.3390/microorganisms10040717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL, Chan BK, Cunningham SA, Goodman KE, Greenwood-Quaintance KE, Harris AD, Hesse S, Maresso A, Nussenblatt V, Pride D, Rybak MJ, Sund Z, van Duin D, Van Tyne D, Patel R; Antibacterial Resistance Leadership Group. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob Agents Chemother 2022;66:e0207121. [PMID: 35041506 DOI: 10.1128/AAC.02071-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
7 Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay J, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers W. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. The Lancet Infectious Diseases 2022. [DOI: 10.1016/s1473-3099(21)00612-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Genevière J, McCallin S, Huttner A, Pham TT, Suva D. A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety. EFORT Open Rev 2021;6:1148-56. [PMID: 35003759 DOI: 10.1302/2058-5241.6.210073] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Matsuki Y, Tanabe S, Yokozawa T, Li S, Oda T. Case report of Community-acquired <i>Pseudomonas aeruginosa</i> Osteomyelitis Caused by an Injury from a Dishwasher. Intern Med . [DOI: 10.2169/internalmedicine.7736-21] [Reference Citation Analysis]
10 Tkhilaishvili T, Potapov E, Starck C, Mulzer J, Falk V, Trampuz A, Schoenrath F. Bacteriophage Therapy as a Treatment Option for Complex Cardiovascular Implant Infection: The German Heart Center Berlin experience. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Silva C, Sá S, Guedes C, Oliveira C, Lima C, Oliveira M, Mendes J, Novais G, Baylina P, Fernandes R. The History and Applications of Phage Therapy in Pseudomonas aeruginosa. Microbiology Research 2022;13:14-37. [DOI: 10.3390/microbiolres13010002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Onsea J, Post V, Buchholz T, Schwegler H, Zeiter S, Wagemans J, Pirnay JP, Merabishvili M, D'Este M, Rotman SG, Trampuz A, Verhofstad MHJ, Obremskey WT, Lavigne R, Richards RG, Moriarty TF, Metsemakers WJ. Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study. Microbiol Spectr 2021;9:e0173621. [PMID: 34908439 DOI: 10.1128/spectrum.01736-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Danis-Wlodarczyk KM, Wozniak DJ, Abedon ST. Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application. Antibiotics (Basel) 2021;10:1497. [PMID: 34943709 DOI: 10.3390/antibiotics10121497] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Ferry T, Kolenda C, Briot T, Souche A, Lustig S, Josse J, Batailler C, Pirot F, Medina M, Leboucher G, Laurent F, On Behalf Of The Lyon Bji Study Group, On Behalf Of The PHAGEinLYON Study Group. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection. Viruses 2021;13:2414. [PMID: 34960683 DOI: 10.3390/v13122414] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Abedon ST, Danis-Wlodarczyk KM, Alves DR. Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy? Pharmaceuticals (Basel) 2021;14:1157. [PMID: 34832939 DOI: 10.3390/ph14111157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Amankwah S, Abdella K, Kassa T. Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents. Nanotechnol Sci Appl 2021;14:161-77. [PMID: 34548785 DOI: 10.2147/NSA.S325594] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
17 Van Nieuwenhuyse B, Galant C, Brichard B, Docquier PL, Djebara S, Pirnay JP, Van der Linden D, Merabishvili M, Chatzis O. A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions. Viruses 2021;13:1898. [PMID: 34696328 DOI: 10.3390/v13101898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Walter N, Deng L, Brochhausen C, Alt V, Rupp M. [Treatment of bone and periprosthetic infections with bacteriophages : A systematic review]. Orthopade 2021. [PMID: 34499212 DOI: 10.1007/s00132-021-04148-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Lensen KDF, Escudero-Sanchez R, Cobo J, Trebše R, Gubavu C, Tedeschi S, Lomas JM, Arvieux C, Rodriguez-Pardo D, Fantoni M, Pais MJG, Jover F, Salles MJC, Sancho I, Sampedro MF, Soriano A, Wouthuyzen-Bakker M, Escmid Study Group Of Implant Associated Infections Esgiai. The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus. J Bone Jt Infect 2021;6:313-9. [PMID: 34422548 DOI: 10.5194/jbji-6-313-2021] [Reference Citation Analysis]
20 Pacios O, Fernández-García L, Bleriot I, Blasco L, González-Bardanca M, López M, Fernández-Cuenca F, Oteo J, Pascual Á, Martínez-Martínez L, Domingo-Calap P, Bou G, Tomás M; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 2021;65:e0090021. [PMID: 34228538 DOI: 10.1128/AAC.00900-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Berryhill BA, Huseby DL, McCall IC, Hughes D, Levin BR. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections. Proc Natl Acad Sci U S A 2021;118:e2008007118. [PMID: 33649203 DOI: 10.1073/pnas.2008007118] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
22 Xu Q, Hu X, Wang Y. Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections. Mol Biotechnol 2021. [PMID: 34309796 DOI: 10.1007/s12033-021-00371-2] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Avershina E, Shapovalova V, Shipulin G. Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. Front Microbiol 2021;12:707330. [PMID: 34367112 DOI: 10.3389/fmicb.2021.707330] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
24 Cano EJ, Caflisch KM, Bollyky PL, Van Belleghem JD, Patel R, Fackler J, Brownstein MJ, Horne B, Biswas B, Henry M, Malagon F, Lewallen DG, Suh GA. Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity. Clin Infect Dis 2021;73:e144-51. [PMID: 32699879 DOI: 10.1093/cid/ciaa705] [Cited by in Crossref: 23] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
25 Liu D, Van Belleghem JD, de Vries CR, Burgener E, Chen Q, Manasherob R, Aronson JR, Amanatullah DF, Tamma PD, Suh GA. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies. Viruses 2021;13:1268. [PMID: 34209836 DOI: 10.3390/v13071268] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
26 Broncano-Lavado A, Santamaría-Corral G, Esteban J, García-Quintanilla M. Advances in Bacteriophage Therapy against Relevant MultiDrug-Resistant Pathogens. Antibiotics (Basel) 2021;10:672. [PMID: 34199889 DOI: 10.3390/antibiotics10060672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
27 Doub JB, Ng VY, Wilson E, Corsini L, Chan BK. Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy. Pharmaceuticals (Basel) 2021;14:231. [PMID: 33800146 DOI: 10.3390/ph14030231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
28 Gibb BP, Hadjiargyrou M. Bacteriophage therapy for bone and joint infections. Bone Joint J 2021;103-B:234-44. [PMID: 33517726 DOI: 10.1302/0301-620X.103B2.BJJ-2020-0452.R2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Allué-Guardia A, Saranathan R, Chan J, Torrelles JB. Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis. Int J Mol Sci 2021;22:E735. [PMID: 33450990 DOI: 10.3390/ijms22020735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Davis CM, McCutcheon JG, Dennis JJ. Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA01. Microorganisms 2021;9:152. [PMID: 33445453 DOI: 10.3390/microorganisms9010152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
31 Van Belleghem JD, Manasherob R, Miȩdzybrodzki R, Rogóż P, Górski A, Suh GA, Bollyky PL, Amanatullah DF. The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections. Front Microbiol 2020;11:591021. [PMID: 33408703 DOI: 10.3389/fmicb.2020.591021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
32 Jägersberg M, Feihl S, Ringel F. Future directions of postoperative spinal implant infections. J Spine Surg 2020;6:814-9. [PMID: 33447687 DOI: 10.21037/jss-20-585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Law N, Aslam S. Phage Therapy: Primer and Role in the Treatment of MDROs. Curr Infect Dis Rep 2020;22. [DOI: 10.1007/s11908-020-00742-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Doub JB. Bacteriophage Therapy for Clinical Biofilm Infections: Parameters That Influence Treatment Protocols and Current Treatment Approaches. Antibiotics (Basel) 2020;9:E799. [PMID: 33198058 DOI: 10.3390/antibiotics9110799] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
35 Clarke AL, De Soir S, Jones JD. The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review. Antibiotics (Basel) 2020;9:E795. [PMID: 33182795 DOI: 10.3390/antibiotics9110795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
36 Chegini Z, Khoshbayan A, Taati Moghadam M, Farahani I, Jazireian P, Shariati A. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob 2020;19:45. [PMID: 32998720 DOI: 10.1186/s12941-020-00389-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
37 Gu Liu C, Green SI, Min L, Clark JR, Salazar KC, Terwilliger AL, Kaplan HB, Trautner BW, Ramig RF, Maresso AW. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio 2020;11:e01462-20. [PMID: 32753497 DOI: 10.1128/mBio.01462-20] [Cited by in Crossref: 23] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
38 Ferry T, Batailler C, Brosset S, Kolenda C, Goutelle S, Sappey-Marinier E, Josse J, Laurent F, Lustig S; Lyon BJI Study Group. Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach. SICOT J 2020;6:26. [PMID: 32633714 DOI: 10.1051/sicotj/2020021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
39 Doub JB, Ng VY, Johnson AJ, Slomka M, Fackler J, Horne B, Brownstein MJ, Henry M, Malagon F, Biswas B. Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection. Antibiotics (Basel) 2020;9:E241. [PMID: 32397354 DOI: 10.3390/antibiotics9050241] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
40 Vrancianu CO, Popa LI, Bleotu C, Chifiriuc MC. Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance. Front Microbiol 2020;11:761. [PMID: 32435238 DOI: 10.3389/fmicb.2020.00761] [Cited by in Crossref: 16] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
41 Lewis R, Clooney AG, Stockdale SR, Buttimer C, Draper LA, Ross RP, Hill C. Isolation of a Novel Jumbo Bacteriophage Effective Against Klebsiella aerogenes. Front Med (Lausanne) 2020;7:67. [PMID: 32185177 DOI: 10.3389/fmed.2020.00067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
42 Ghose C, Euler CW. Gram-Negative Bacterial Lysins. Antibiotics (Basel) 2020;9:E74. [PMID: 32054067 DOI: 10.3390/antibiotics9020074] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 22.0] [Reference Citation Analysis]
43 Tkhilaishvili T, Wang L, Tavanti A, Trampuz A, Di Luca M. Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant Staphylococcus aureus: Prevention and Eradication of Biofilm Formation and Control of a Systemic Infection of Galleria mellonella Larvae. Front Microbiol 2020;11:110. [PMID: 32117136 DOI: 10.3389/fmicb.2020.00110] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
44 Aslam S, Schooley RT. What's Old Is New Again: Bacteriophage Therapy in the 21st Century. Antimicrob Agents Chemother 2019;64:e01987-19. [PMID: 31685458 DOI: 10.1128/AAC.01987-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
45 Caflisch KM, Suh GA, Patel R. Biological challenges of phage therapy and proposed solutions: a literature review. Expert Rev Anti Infect Ther 2019;17:1011-41. [PMID: 31735090 DOI: 10.1080/14787210.2019.1694905] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]